Insiders · Profile

Brainard Diana

Chief Executive Officer at Kalaris Therapeutics. Filing since 3 Aug 2020. CIK 0001818070

Company

Date

Role

Action

Shares

Amount

Of holding

KLRS Kalaris Therapeutics, Inc.

19 Nov 2024

Chief Executive Officer

Sold at will

8,706

$4.78K

1.2%

KLRS Kalaris Therapeutics, Inc.

5 Nov 2024

Chief Executive Officer

Sold at will

10,609

$9.18K

1.4%

KLRS Kalaris Therapeutics, Inc.

21 Oct 2024

Chief Executive Officer

Sold at will

9,752

$7.60K

1.3%

KLRS Kalaris Therapeutics, Inc.

3 Oct 2024

Chief Executive Officer

Sold at will

1,493

$1.22K

0.2%

KLRS Kalaris Therapeutics, Inc.

20 Aug 2024

Chief Executive Officer

Sold at will

5,390

$4.00K

0.7%

KLRS Kalaris Therapeutics, Inc.

19 Aug 2024

Chief Executive Officer

Sold at will

3,091

$2.35K

0.4%

KLRS Kalaris Therapeutics, Inc.

5 Aug 2024

Chief Executive Officer

Sold at will

10,847

$7.97K

1.4%

KLRS Kalaris Therapeutics, Inc.

19 Jul 2024

Chief Executive Officer

Sold at will

9,731

$7.30K

1.2%

KLRS Kalaris Therapeutics, Inc.

2 Jul 2024

Chief Executive Officer

Sold at will

1,489

$1.07K

0.2%

KLRS Kalaris Therapeutics, Inc.

21 May 2024

Chief Executive Officer

Sold at will

5,149

$4.08K

0.7%

KLRS Kalaris Therapeutics, Inc.

17 May 2024

Chief Executive Officer

Sold at will

3,075

$2.30K

0.4%

KLRS Kalaris Therapeutics, Inc.

3 May 2024

Chief Executive Officer

Sold at will

10,240

$8.15K

1.3%

KLRS Kalaris Therapeutics, Inc.

19 Apr 2024

Chief Executive Officer

Sold at will

9,601

$7.21K

1.2%

KLRS Kalaris Therapeutics, Inc.

2 Apr 2024

Chief Executive Officer

Sold at will

1,533

$1.18K

0.2%

KLRS Kalaris Therapeutics, Inc.

21 Feb 2024

Chief Executive Officer

Sold at will

5,155

$3.65K

0.6%

KLRS Kalaris Therapeutics, Inc.

20 Feb 2024

Chief Executive Officer

Sold at will

3,097

$2.15K

0.4%

KLRS Kalaris Therapeutics, Inc.

5 Feb 2024

Chief Executive Officer

Sold at will

41,421

$27.75K

4.8%

KLRS Kalaris Therapeutics, Inc.

23 Jan 2024

Chief Executive Officer

Sold at will

9,500

$6.37K

1.1%

KLRS Kalaris Therapeutics, Inc.

4 Jan 2024

Chief Executive Officer

Sold at will

1,664

$1.06K

0.2%

KLRS Kalaris Therapeutics, Inc.

20 Nov 2023

Chief Executive Officer

Sold on a plan

4,382

$7.41K

0.5%

KLRS Kalaris Therapeutics, Inc.

17 Nov 2023

Chief Executive Officer

Sold on a plan

2,689

$4.39K

0.3%

KLRS Kalaris Therapeutics, Inc.

19 Oct 2023

Chief Executive Officer

Sold on a plan

8,581

$13.56K

1.0%

KLRS Kalaris Therapeutics, Inc.

3 Oct 2023

Chief Executive Officer

Sold on a plan

1,325

$2.62K

0.1%

KLRS Kalaris Therapeutics, Inc.

18 Aug 2023

Chief Executive Officer

Sold on a plan

4,055

$11.31K

0.5%

KLRS Kalaris Therapeutics, Inc.

17 Aug 2023

Chief Executive Officer

Sold on a plan

11,361

$28.35K

1.3%

KLRS Kalaris Therapeutics, Inc.

19 Jul 2023

Chief Executive Officer

Sold on a plan

8,342

$29.71K

0.9%

KLRS Kalaris Therapeutics, Inc.

5 Jul 2023

Chief Executive Officer

Sold on a plan

5,275

$16.06K

0.6%

KLRS Kalaris Therapeutics, Inc.

18 May 2023

Chief Executive Officer

Sold on a plan

4,536

$19.11K

0.5%

KLRS Kalaris Therapeutics, Inc.

19 Apr 2023

Chief Executive Officer

Sold on a plan

8,408

$31.18K

0.9%

KLRS Kalaris Therapeutics, Inc.

21 Feb 2023

Chief Executive Officer

Sold, plan not stated

5,122

$33.94K

0.5%

KLRS Kalaris Therapeutics, Inc.

19 Jan 2023

Chief Executive Officer

Sold, plan not stated

34,435

$174.85K

5.4%

KLRS Kalaris Therapeutics, Inc.

18 Nov 2022

Chief Executive Officer

Sold, plan not stated

4,515

$32.81K

0.7%

KLRS Kalaris Therapeutics, Inc.

18 Aug 2022

Chief Executive Officer

Sold, plan not stated

4,564

$35.43K

0.7%

KLRS Kalaris Therapeutics, Inc.

18 May 2022

Chief Executive Officer

Sold, plan not stated

29,135

$126.26K

5.6%

KLRS Kalaris Therapeutics, Inc.

3 Aug 2020

Director

Bought

6,300

$107.10K

opened

35 decisions on file.